NIH-funded research NIH-funded research

Understanding how radiation therapy affects the immune response in cervical cancer

Official title: METEOR-Comprehensive Radiobiology Assessment TRial (METEOR-CRATR)

Funded at Washington University · NIH-10912699 · Data updated 2026-11-12

This study is looking at how immune cells and tumors work together in patients with locally advanced cervical cancer who are receiving radiation and cisplatin, to help find ways to improve treatment and make it more effective for the future.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$59,098
NIH project number5U54CA274318-02
Project IDNIH-10912699 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with locally advanced cervical cancer who are receiving radiation therapy and cisplatin.

Less likely to help

Patients with early-stage cervical cancer or those not undergoing radiation therapy may not benefit from this research.

What this research studies

This research investigates the interactions between immune cells and tumors in patients with locally advanced cervical cancer undergoing radiation therapy combined with cisplatin. By analyzing the tumor microenvironment, the study aims to understand how these treatments influence immune responses and contribute to treatment resistance. Patients will be involved in a molecular characterization trial that collects detailed clinical and biological data to improve future treatment strategies. The goal is to identify factors that may lead to better outcomes and reduce the failure rates associated with current therapies.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies that enhance anti-tumor immunity and reduce recurrence rates in cervical cancer patients.

How similar studies have gone: Previous research has shown promising results in understanding tumor-immune interactions in other cancer types, suggesting potential for success in this novel approach.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Robinson, Clifford Grant — Washington University
  • Study coordinator: Robinson, Clifford Grant

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.